205 related articles for article (PubMed ID: 9164230)
1. Recommended breast cancer surveillance guidelines. American Society of Clinical Oncology.
J Clin Oncol; 1997 May; 15(5):2149-56. PubMed ID: 9164230
[TBL] [Abstract][Full Text] [Related]
2. American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines.
Smith TJ; Davidson NE; Schapira DV; Grunfeld E; Muss HB; Vogel VG; Somerfield MR
J Clin Oncol; 1999 Mar; 17(3):1080-2. PubMed ID: 10071303
[TBL] [Abstract][Full Text] [Related]
3. Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology.
Desch CE; Benson AB; Smith TJ; Flynn PJ; Krause C; Loprinzi CL; Minsky BD; Petrelli NJ; Pfister DG; Somerfield MR
J Clin Oncol; 1999 Apr; 17(4):1312. PubMed ID: 10561194
[TBL] [Abstract][Full Text] [Related]
4. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting.
Khatcheressian JL; Wolff AC; Smith TJ; Grunfeld E; Muss HB; Vogel VG; Halberg F; Somerfield MR; Davidson NE;
J Clin Oncol; 2006 Nov; 24(31):5091-7. PubMed ID: 17033037
[TBL] [Abstract][Full Text] [Related]
5. 1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7, 1997 by the American Society of Clinical Oncology.
J Clin Oncol; 1998 Feb; 16(2):793-5. PubMed ID: 9469371
[TBL] [Abstract][Full Text] [Related]
6. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology.
J Clin Oncol; 1996 Oct; 14(10):2843-77. PubMed ID: 8874347
[TBL] [Abstract][Full Text] [Related]
7. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.
J Clin Oncol; 1997 Aug; 15(8):2996-3018. PubMed ID: 9256144
[TBL] [Abstract][Full Text] [Related]
8. American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel.
Hillner BE; Ingle JN; Berenson JR; Janjan NA; Albain KS; Lipton A; Yee G; Biermann JS; Chlebowski RT; Pfister DG
J Clin Oncol; 2000 Mar; 18(6):1378-91. PubMed ID: 10715310
[TBL] [Abstract][Full Text] [Related]
9. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology.
Bast RC; Ravdin P; Hayes DF; Bates S; Fritsche H; Jessup JM; Kemeny N; Locker GY; Mennel RG; Somerfield MR;
J Clin Oncol; 2001 Mar; 19(6):1865-78. PubMed ID: 11251019
[TBL] [Abstract][Full Text] [Related]
10. Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology.
Schiffer CA; Anderson KC; Bennett CL; Bernstein S; Elting LS; Goldsmith M; Goldstein M; Hume H; McCullough JJ; McIntyre RE; Powell BL; Rainey JM; Rowley SD; Rebulla P; Troner MB; Wagnon AH;
J Clin Oncol; 2001 Mar; 19(5):1519-38. PubMed ID: 11230498
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update.
Khatcheressian JL; Hurley P; Bantug E; Esserman LJ; Grunfeld E; Halberg F; Hantel A; Henry NL; Muss HB; Smith TJ; Vogel VG; Wolff AC; Somerfield MR; Davidson NE;
J Clin Oncol; 2013 Mar; 31(7):961-5. PubMed ID: 23129741
[TBL] [Abstract][Full Text] [Related]
12. American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene.
Chlebowski RT; Collyar DE; Somerfield MR; Pfister DG
J Clin Oncol; 1999 Jun; 17(6):1939-55. PubMed ID: 10561236
[TBL] [Abstract][Full Text] [Related]
13. Preventive health care, 1999 update: 3. Follow-up after breast cancer. Canadian Task Force on Preventive Health Care.
Temple LK; Wang EE; McLeod RS
CMAJ; 1999 Oct; 161(8):1001-8. PubMed ID: 10551200
[TBL] [Abstract][Full Text] [Related]
14. Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.
Bezjak A; Temin S; Franklin G; Giaccone G; Govindan R; Johnson ML; Rimner A; Schneider BJ; Strawn J; Azzoli CG
J Clin Oncol; 2015 Jun; 33(18):2100-5. PubMed ID: 25944914
[TBL] [Abstract][Full Text] [Related]
15. Surveillance and beliefs about follow-up care among long-term breast cancer survivors: a comparison of primary care and oncology providers.
Risendal BC; Sedjo RL; Giuliano AR; Vadaparampil S; Jacobsen PB; Kilbourn K; Barón A; Byers T
J Cancer Surviv; 2016 Feb; 10(1):96-102. PubMed ID: 26070279
[TBL] [Abstract][Full Text] [Related]
16. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology.
Recht A; Edge SB; Solin LJ; Robinson DS; Estabrook A; Fine RE; Fleming GF; Formenti S; Hudis C; Kirshner JJ; Krause DA; Kuske RR; Langer AS; Sledge GW; Whelan TJ; Pfister DG;
J Clin Oncol; 2001 Mar; 19(5):1539-69. PubMed ID: 11230499
[TBL] [Abstract][Full Text] [Related]
17. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002.
Winer EP; Hudis C; Burstein HJ; Chlebowski RT; Ingle JN; Edge SB; Mamounas EP; Gralow J; Goldstein LJ; Pritchard KI; Braun S; Cobleigh MA; Langer AS; Perotti J; Powles TJ; Whelan TJ; Browman GP
J Clin Oncol; 2002 Aug; 20(15):3317-27. PubMed ID: 12149306
[TBL] [Abstract][Full Text] [Related]
18. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
19. American Society of Clinical Oncology-recommended surveillance and physician specialty among long-term breast cancer survivors.
Hollowell K; Olmsted CL; Richardson AS; Pittman HK; Bellin L; Tafra L; Verbanac KM
Cancer; 2010 May; 116(9):2090-8. PubMed ID: 20198707
[TBL] [Abstract][Full Text] [Related]
20. American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition.
Chlebowski RT; Col N; Winer EP; Collyar DE; Cummings SR; Vogel VG; Burstein HJ; Eisen A; Lipkus I; Pfister DG;
J Clin Oncol; 2002 Aug; 20(15):3328-43. PubMed ID: 12149307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
